Modulators of nuclear receptors

Details for Australian Patent Application No. 2005280487 (hide)

Owner Exelixis, Inc.

Inventors Wang, Yong; Bannen, Lynne Canne; Stevens, William C., Jr.; Khoury, Richard G.; Jammalamadaka Vasu; Bayne, Christopher D.; Parks, Jason Jevious; Mohan, Raju; Wang, Haixia; Johnson, Alan T.; Huang, Ping; Nyman, Michael C.; Xu, Wei; Xie, Yinong; Lu, Shao-Po; Chan, Diva Sze-Ming; Schweiger, Edwin J.; Mac, Morrison B.

Agent Davies Collison Cave

Pub. Number AU-A-2005280487

PCT Pub. Number WO2006/025979

Priority 10/899,458 24.07.04 US

Filing date 24 July 2005

Wipo publication date 9 March 2006

International Classifications

A61K 31/4439 (2006.01)

Event Publications

1 February 2007 PCT application entered the National Phase

  PCT publication WO2006/025979 Priority application(s): WO2006/025979

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005280496-Use of ALK 5 inhibitors to modulate or inhibit myostatin activity leading to increased lean tissue accretion in animals

2005280483-Ultrafine hydrous kaolin pigments, methods of making the pigments, and methods of using the pigments in gloss paint formulations